your market intelligence analyst
Search Results
20 results
Your search is now limited to «Excipients» expert search.
As a result of this sunset review, the Department of Commerce (Commerce) finds that revocation of the antidumping duty (AD) order on citric acid and certain citrate salts from the People's Republic of China (China) would be likely to lead to a continuation or recurrence of dumping, at the levels identified in the ``Final Results of Sunset Review'' section of this notice.
Seeking Alpha 08/14/2020 12:17
PLx Pharma Inc. (NASDAQ:PLXP) Q2 2020 Earnings Conference Call August 14, 2020 08:30 AM ET Company Participants Lisa Wilson - Investor Relations Natasha Giordano - President & Chief Executive Officer Rita O'Connor - Chief Financial Officer Conference Call Participants Elliot Wilbur - Raymond James Jason Butler - JMP Securities Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the PLx Pharma Q2 2020 Earnings Call.
Draft public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) including recommendations regarding contamination of herbal medicinal products with pyrrolizidine alkaloids - Revision 1.
Seeking Alpha 08/13/2020 22:58
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q2 2020 Earnings Conference Call August 13, 2020 04:30 PM ET Company Participants Paul Sagan - Investor Relations Glenn Mattes - President and Chief Executive Officer Kirk Coleman - Chief Financial Officer Chris Cano - Vice President-Business Development Bill Williams - University of Texas, Austin Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals’ Second Quarter 2020 Financial Results Conference Call.
Kukmin Ilbo (Korea) 08/11/2020 05:14
종근당은 복약편의성이 개선된 치주질환 치료제 ‘이튼큐 플러스’를 출시했다. 이튼큐 플러스는 옥수수불검화정량추출물 단일제제인 이튼큐에 후박추출물을 추가한 생약 성분의 복합제다. 주성분인 옥수수불검화정량추출물은 치주인대의 재생을 도와 치아가 흔들리는 것을 막고 치조골을 재건시켜 잇몸 속 기초를 튼튼하게 하는데 도움을 준다. 후박추출물은 치주질환의 원인균에 대한 항균효과와 항염효과가 우수해 잇몸 염증에 대한 저항력을 강화시켜준다. 또 이튼큐 플러스는 장기 복용에도 부작용이 없는 생약 성분 치료제로 안전성이 입증됐다. 종근당이 독자 개발한 정제 축소기술 iLET(Innovative Low Excipient Tablet) 특허공법을 적용해 현재 출시되어 있는 동일성분 제품 중 정제 사이즈를 가장 작게 줄임으로써 다수의 약물을 함께 복용하는 중·장년층 환자의 복약편의성을 개선한 것이 특징이다. 종근당 관계자는 “치주질환 치료제는 장기 복용하는 환자가 많고 용법·용량에 맞춰 복용하는 복약순응도가 치료에 큰 영향을 미친다”라며 “복약편의성을 개선하고 안전성이 입증된 이튼큐 플러스가 치주질환 치료에 큰 도움을 줄 것”이라고 말했다. 조민규 쿠키뉴스 기자.
Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical formulation information provided herein.
Seeking Alpha 08/09/2020 23:56
Surmodics, Inc. (NASDAQ:SRDX) Q3 2020 Earnings Conference Call August 5, 2020 17:00 ET Company Participants Tim Arens - Vice President, Finance & Chief Financial Officer Gary Maharaj - Chief Executive Officer Conference Call Participants Jim Sidoti - Sidoti & Company Brooks O'Neil - Lake Street Capital Markets David Saxon - Needham & Company Presentation Operator Good day, and welcome to the Surmodics Third Quarter Fiscal 2020 Earnings Conference Call.
Seeking Alpha 08/09/2020 05:32
Kezar Life Sciences, Inc. (NASDAQ:KZR) Q2 2020 Earnings Conference Call August 5, 2020 16:30 ET Company Participants Celia Economides - Senior Vice President of Strategy & External Affairs John Fowler - Chief Executive Officer Noreen Henig - Chief Medical Officer Christopher Kirk - President & Chief Scientific Officer Marc Belsky - Chief Financial Officer Conference Call Participants Blair Cohen - H.C.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications